ArticleIJTLD open2026
Innovation and progress towards TB elimination in New South Wales, Australia.
Article in IJTLD open, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
settingDespite maintaining a low TB incidence (<10/100,000 population) for decades, progress towards TB elimination targets in Australia remains elusive.
objectiveWe describe innovative approaches to improve TB care and control and programmatic components implemented to advance local TB elimination.
resultsAround 90% of people diagnosed with TB in New South Wales (NSW) were born outside Australia, with the greatest number of cases born in India, the Philippines, Nepal, and Vietnam. Routine whole genome sequencing allows local transmission tracking, and optimised data pathways provide better oversight of key performance indicators (KPIs), including the treatment of TB infection. Further efforts are underway to increase primary care involvement in TB preventive treatment (TPT) provision and to achieve stronger cultural engagement of vulnerable groups.
conclusionProgress towards TB elimination in low-incidence settings requires renewed commitment and innovation, with careful consideration of local context. In NSW, key areas of innovation include improved transmission surveillance, enhanced data for KPI monitoring and optimised care of drug-resistant TB; however, reducing TB vulnerability, universal contact screening, and increased TPT coverage remain ongoing challenges.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.